Open main menu ☰
HealingWell
Search Close Search
Health Conditions
Allergies Alzheimer's Disease Anxiety & Panic Disorders Arthritis Breast Cancer Chronic Illness Crohn's Disease Depression Diabetes
Fibromyalgia GERD & Acid Reflux Irritable Bowel Syndrome Lupus Lyme Disease Migraine Headache Multiple Sclerosis Prostate Cancer Ulcerative Colitis

View Conditions A to Z »
Support Forums
Anxiety & Panic Disorders Bipolar Disorder Breast Cancer Chronic Pain Crohn's Disease Depression Diabetes Fibromyalgia GERD & Acid Reflux
Hepatitis Irritable Bowel Syndrome Lupus Lyme Disease Multiple Sclerosis Ostomies Prostate Cancer Rheumatoid Arthritis Ulcerative Colitis

View Forums A to Z »
Log In
Join Us
Close main menu ×
  • Home
  • Health Conditions
    • All Conditions
    • Allergies
    • Alzheimer's Disease
    • Anxiety & Panic Disorders
    • Arthritis
    • Breast Cancer
    • Chronic Illness
    • Crohn's Disease
    • Depression
    • Diabetes
    • Fibromyalgia
    • GERD & Acid Reflux
    • Irritable Bowel Syndrome
    • Lupus
    • Lyme Disease
    • Migraine Headache
    • Multiple Sclerosis
    • Prostate Cancer
    • Ulcerative Colitis
  • Support Forums
    • All Forums
    • Anxiety & Panic Disorders
    • Bipolar Disorder
    • Breast Cancer
    • Chronic Pain
    • Crohn's Disease
    • Depression
    • Diabetes
    • Fibromyalgia
    • GERD & Acid Reflux
    • Hepatitis
    • Irritable Bowel Syndrome
    • Lupus
    • Lyme Disease
    • Multiple Sclerosis
    • Ostomies
    • Prostate Cancer
    • Rheumatoid Arthritis
    • Ulcerative Colitis
  • Log In
  • Join Us
Join Us
☰
Forum Home| Forum Rules| Moderators| Active Topics| Help| Log In

Unpopular

Support Forums
>
Lyme Disease
✚ New Topic ✚ Reply
1 23
❬ ❬ Previous Thread |Next Thread ❭ ❭
profile picture
Georgia Hunter
Veteran Member
Joined : May 2012
Posts : 2601
Posted 12/23/2020 6:25 AM (GMT -7)

potsnpans said...
"It's about limiting or reducing viral load and more CA activity increases viral load IMO."

For your hypothesis to seem plausible to me, could you at least attempt to respond to the 3 points in my post above? Tackling the first point I think is crucial to explaining how "CA activity increases viral load".
.


An older study I read showed that TB could not grow in oxygen, it required CO2 to grow. This may also apply to SARS-COv-2 and the way it see it is that the virus enters the cell at the ACE2 receptor but there are things that can bind the inside of the ACE2 receptor and prevent entry into the cell. Carbonic anhydrase is such an item. With high oxygen levels and little CO2 to deal with, CA stays attached and prevents entry. With inadequate cellular buffering capacity, zinc and/or Vitamin D are in lower concentrations and CA doesn't stay attached to ACE2. This allows the viral replication process to occur after the virus enters the cell. In a young healthy person, little virus gains entry. This is not an all or none situation, some virus will get through because CA is always in use. The amount of viral entry is what is limited in a healthy person and the replication that does occur is less because Vit D and zinc are bound to CA which may inhibit the virus from binding CA. More zinc and Vit D, less viral replication and less severity.
profile picture
Georgia Hunter
Veteran Member
Joined : May 2012
Posts : 2601
Posted 12/23/2020 6:38 AM (GMT -7)
Most of us Lyme people know that modern medicine has failed us. In general, you know what I mean. The people telling us the science are wrong (IDSA). I feel this is a similar situation. Little or nothing they have said so far has worked or IMO, been correct. Rebreathed air is the problem with COVID, it is not influenza. If you want to stop spit and coughs, wear a mask and you can do that. SARS-Cov-2 goes through a mask like it isn't even there. I was looking at a standard medical mask under my microscope the other day and I hate to tell you, it's a very open weave. I would bet it stopped less than 50% of airborne viral particles. Some will argue that 50% is better than nothing, I say it is not. How long you stay in the rebreathed air and how concentrated the CO2 level are more important. If it does bind CA like all indications point to, then your increase in CA activity due to increased CO2 from wearing a mask would be much more important than a 50% drop in circulating viral laden droplets. I want to stop this virus and I will do whatever I can to do it, but mask wearing won't stop it. To stop it, you have to ventilate indoor areas and keep CO2 levels down.
profile picture
astroman
Veteran Member
Joined : Mar 2014
Posts : 7509
Posted 12/23/2020 7:38 AM (GMT -7)
"If you want to stop spit and coughs, wear a mask and you can do that. SARS-Cov-2 goes through a mask like it isn't even there. I was looking at a standard medical mask under my microscope the other day and I hate to tell you, it's a very open weave."

N95.

"I would bet it stopped less than 50% of airborne viral particles."

- That's a guesstamate - but it would still slow the trajectory of what goes through, which is my point. Even a bug screen slows trajectory of moving air.

Your typical big box style grocery store and home store has decent air circulation and high ceiling which gives you increased volumes. Old, smaller buildings, low ceilings- not so much, I would just avoid such places if they have high numbers of people, mask or no masks. Many states retraced covid to bars and restaurants.
profile picture
potsnpans
Veteran Member
Joined : Mar 2019
Posts : 799
Posted 12/23/2020 7:16 PM (GMT -7)

GH said...
An older study I read showed that TB could not grow in oxygen, it required CO2 to grow. This may also apply to SARS-COv-2...


I’m hesitant but I have to ask... Why are you looking for similarities between sars-cov-2 and the bacteria that cause TB?

GH said...
...the way it see it is that the virus enters the cell at the ACE2 receptor but there are things that can bind the inside of the ACE2 receptor and prevent entry into the cell. Carbonic anhydrase is such an item. With high oxygen levels and little CO2 to deal with, CA stays attached and prevents entry. With inadequate cellular buffering capacity, zinc and/or Vitamin D are in lower concentrations and CA doesn't stay attached to ACE2. This allows the viral replication process to occur after the virus enters the cell.


So sars-cov-2 is binding ACE2 and CA is just in its way preventing it from entering the cell (until blood CO2 rises and CA needs to leave)?

What makes you think CA would be able to block entry in this way?

It seems this process would not lead to RBC damage in covid-19 as RBCs do not express ACE2.

Post Edited (potsnpans) : 12/24/2020 7:55:51 AM (GMT-7)

profile picture
potsnpans
Veteran Member
Joined : Mar 2019
Posts : 799
Posted 12/24/2020 7:50 AM (GMT -7)

GH said...
Rebreathed air is the problem with COVID, it is not influenza.


Agreed, but this is because sars-cov-2 is more airborne. This gives us no insight into whether CO2 might be playing a part in its transmission or pathology.

Although they are both respiratory viruses, sars-cov-2 is infecting lung tissue to a greater extent.. influenza more nose and throat. This is probably how sars-cov-2 becomes more aerosolized than influenza does, and why masks, as you said, may not work as well as they do for influenza. This does not mean masks are harmful, which was the main point of contention between you and I in the last thread and I guess this one as well.
profile picture
Georgia Hunter
Veteran Member
Joined : May 2012
Posts : 2601
Posted 12/24/2020 8:21 AM (GMT -7)
I am pretty adept at cross referencing health related topics. Some of my searches show no results, some show many. The CO2 TB connection just came from a lot of reading. CA inhibitors like acetazolamide have an inhibitory effect on Pseudomonas and CA is linked directly to disease progression in malaria (and I assumed other) diseases. We know that antibiotics and at least one pathogen bind CA inside the cell. There are 16 known CA and I focused in on CA II and CA IV. One inside the cell, one outside the cell. There are multiple references now that refer to CA and it's role in COVID. They are looking for answers like I am but we are on the same page. Back in March, I stated I thought the terminal protein on SARs-Cov-2 was 32 kDa and haven't seen anything to change that opinion. CA is bound to ACE2 inside the cell but is released to move around. Zn and Vitamin D levels play a role in this I am certain. When more CO2 is present, CA is released to do what it does. Does that open up the ACE2 receptor for easier viral entry? I believe we need less CO2 in our system to lessen viral load.

When I looked into "What would happen if SARs-Cov-2 bound CA?" is when I came up with my hypothesis. The progression of disease for COVID-19 directly parallels the inconsistent activity of CA. It's a intracellular acid-base problem that must be rectified at any cost. Sometimes that cost leads to one's death.

Astro - my store with an 8 ft ceiling and small square footage is the one we have CO2 issues with. It also has more employees and more foot traffic. Trajectory doesn't play a big role in COVID as the particles can linger for hours. Scientists pulled the virus out of the air 16 feet from a bed ridden patient. SARs-Cov-2 is not influenza. I agree with the ceiling height, building volume plays a big role because of the air circulation.
profile picture
Georgia Hunter
Veteran Member
Joined : May 2012
Posts : 2601
Posted 12/24/2020 8:32 AM (GMT -7)
There are basically two types of COVID patients, one that "hasn't gone over the hump" and one that has. The hump I am referring to is the cytokine cascade that occurs when patients start to go down hill. These are the people they used to put on the ventilator to keep them breathing. The problem is that "going over the hump" involves CA not working inside the cell and eventually working too good inside the cell. A little viral load, CA can still function. With a lot of viral load, CA can not. As more virus is produced, it binds CA and the acid/base issues occur. Not systemic acid/base issues, cellular. The kind that cause ROS and free radicals. It's basically a system killer. CA is pH and zinc dependent and since there are so many isoforms of CA, there are likely multiple issues going on simultaneously.
profile picture
potsnpans
Veteran Member
Joined : Mar 2019
Posts : 799
Posted 12/24/2020 8:49 AM (GMT -7)

GH said...
When more CO2 is present, CA is released to do what it does. Does that open up the ACE2 receptor for easier viral entry?


Well that's what I'm asking about.. is it physically possible for CA to block entry in the first place, and why should we believe that it does? Seems to be the crux of your argument around the amount of breathed CO2 increasing viral load.. I thought you would have more insight here.

GH said...
When I looked into "What would happen if SARs-Cov-2 bound CA?" is when I came up with my hypothesis.


Why would a virus evolve to bind an enzyme that prevents it from replicating?
profile picture
Georgia Hunter
Veteran Member
Joined : May 2012
Posts : 2601
Posted 12/24/2020 10:17 AM (GMT -7)
Number one, this virus didn't evolve. Number two, survival of the fittest. Sicker, less healthier people would be more vulnerable to such a virus or pathogen. The binding of the CO2 is what starts the downturn in our health. It may be only secondary to increased viral load. It seems higher Vitamin D levels keep people from becoming ill from the virus. It's bound to CA when it's present.
profile picture
potsnpans
Veteran Member
Joined : Mar 2019
Posts : 799
Posted 12/24/2020 10:32 AM (GMT -7)

Georgia Hunter said...
Number one, this virus didn't evolve.


Are you now suggesting that the virus was genetically engineered/modified to bind CA? Please go on...

I think it's much more likely that sars-cov-2 originated in nature. Just how many leaps of faith am I going to have to make here to find support for your hypothesis?

I still would like to know if it's even physically possible for CA to block viral entry into cells w/ ACE-2.. regardless of whether the virus was engineered to bind CA or not.

Georgia Hunter said...
Number two, survival of the fittest. Sicker, less healthier people would be more vulnerable to such a virus or pathogen.


So it's selecting for hosts that it would be more likely to kill? ... doesn't really add up.

Maybe I'm misunderstanding you, but "survival of the fittest" means virus vs virus with a random mutation.. not virus vs host. For a feature like binding CA to win out, it needs to somehow have a net positive effect on replication.. or maybe something to do with transmission. Evolution is not always so straight forward of course, and if you're saying that the virus was genetically modified, then I guess it's possible that this wouldn't apply at all.

Post Edited (potsnpans) : 12/25/2020 9:17:05 PM (GMT-7)

profile picture
potsnpans
Veteran Member
Joined : Mar 2019
Posts : 799
Posted 12/24/2020 12:56 PM (GMT -7)

Georgia Hunter said...
CA inhibitors like acetazolamide have an inhibitory effect on Pseudomonas and CA is linked directly to disease progression in malaria (and I assumed other) diseases.


Malaria is caused by a parasite similar to babesia that reproduces inside RBCs. Viruses cannot replicate inside RBCs as I mentioned in a previous post.

I don't understand the pseudomonas (or TB) link to sars-cov-2 either. Has there been experimentation with CA inhibitors on covid-19 patients?

I'm kinda sticking with an analysis of the claim "CA activity increases viral load" for now, since that seemed to be so central to your thinking from the beginning.
profile picture
Georgia Hunter
Veteran Member
Joined : May 2012
Posts : 2601
Posted 12/26/2020 3:20 AM (GMT -7)
Hard to keep up will all the questions, here is a quote:

"Viruses cannot attack cells that do not bear the appropriate receptors, but they will attempt to infect cells that do, even if those cells are not suitable for viral propagation. If the receptor-expressing cell cannot support replication of the virus, then the virus will spend itself fruitlessly in an attempt to infect it. This idea can be advantageously applied by using selective expression of viral receptors to redirect virus to nonproductive cells, thus protecting susceptible tissues. We propose that erythrocytes are the ideal instrument for this strategy, because these cells are present in vast numbers, permeate every organ, are easily manipulated, are relatively disposable, and cannot serve as hosts for viral replication.

Erythrocytes are simultaneously the most numerous and the simplest cells in the body. In their mature form, they lack the nuclei and organelles required to replicate nucleic acids and elaborate proteins. Because viruses depend on the use of the host cell machinery to replicate, erythrocytes are invulnerable to viral infection. The redirection of virus to erythrocytes has the potential to attenuate infection by leading virions to a dead end, leaving fewer infectious particles free to invade susceptible tissues."

This is one way the body tries to reduce viral load but at the same time, it is reducing oxygen carrying capacity by the virus binding heme oxygenase II. At some point, the viral load overcomes the strategy.

As for experiments with CA Inhibitors, yes, they have been done. In low doses early in the disease process, they were beneficial. At a point later in disease progression, they become extremely detrimental. This follows my thinking.

I don't agree with your statement on selecting hosts it would more likely kill. A virus's goal is to spread and the ultimate outcome of the host is irrelevant if it spreads. Pathogens have always done this, it is nothing new. The only issue is with E bola which kills the host so fast if doesn't have time to spread. SARS-COv-2 doesn't have that problem.

I believe the virus was made in a lab (by Americans) and either got out accidentally in Wuhan or was intentionally released. The North Carolina professor didn't get arrested for making cookies and it has been hush-hush since then.

As far CA, it is bound inside the ACE2 receptor in a complex. There are a couple of natural isoforms of the ACE2 receptor in humans, an open form and a closed form. The intracellular components bound to that receptor can alter the isoform. I have not found that anywhere in the literature for ACE2 but that is the basis of my hypothesis. Internal molecules often determine the exterior configuration of a membrane bound molecule. That is just common molecular biology. As carbonic anhydrase is released from the complex, it opens the ACE2 receptor. That the basis of my thoughts in a nutshell. The more CO2 inside the cell, the more CA is released. This allows viral entry and once inside, it binds CA or it could possibly bind the inside of the ACE2 and prohibit CA reattachment to the ACE2. Either way, there is a reduction in CA activity. I believe this is absolutely zinc related in some way. Since CA is pH dependent, it fails to work at some point which leads to massive ROS and oxidative stress. Early on during the pandemic, they didn't give supplemental oxygen for fear of disseminating the virus. Now, O2 is standard therapy and the survival rates have gone way up.

Vitamin D binds CA. People with high Vitamin D don't have issues with COVID-19. Since supplementing with higher doses of Vitamin D, the survival rates have gone up. Both O2 and Vitamin D increasing survival goes along with my hypothesis. Limiting CO2 would be another and it was shown to be true with TB patients. That is how I came across the literature. The Pseudomonas reference came from a CA study which would theoretically support my hypothesis as well. Please don't go into bacteria, viruses, and protozoans being different. I am aware of the differences. The fact that CA is already known to be bound by pathogens is the point I was trying to make.
profile picture
Pillin
Regular Member
Joined : May 2017
Posts : 68
Posted 12/26/2020 12:18 PM (GMT -7)
So boring the mask discussion.

Why does poeple makes it a political philosophical or religious issue?

Simply a nonsense. If you could ask those who died because of not wearing the mask, you would change your mind.

Merry Christmas to all!
profile picture
Georgia Hunter
Veteran Member
Joined : May 2012
Posts : 2601
Posted 12/26/2020 4:30 PM (GMT -7)

Pillin said...
So boring the mask discussion.

Why does poeple makes it a political philosophical or religious issue?

Simply a nonsense. If you could ask those who died because of not wearing the mask, you would change your mind.

Merry Christmas to all!

I know multiple people who have died and got COVID while wearing a mask. Early on, I advocated that everyone should wear a mask. If you read what I read, you would change your mind. It has nothing to do with politics. If you don't have anything positive to add to this thread, please refrain from making statements about politics.
profile picture
potsnpans
Veteran Member
Joined : Mar 2019
Posts : 799
Posted 12/26/2020 9:44 PM (GMT -7)

Georgia Hunter said...
Hard to keep up will all the questions...


Well you've been saying all along that “increased CA activity from wearing masks increases viral load” and that “it's all about viral load” so my essential questions have been around that. When you answer with pseudomonas and TB, then I have to ask additional questions like "what does that have to do with sars-cov-2 increasing viral load?" Malaria which reproduces inside RBCs.. why bring it up when viruses cannot reproduce inside RBCs? I'm not trying to insult your intelligence or anything.. just trying to stay on track and making sure I am understanding you correctly.

The quote you provided explains how RBCs can be used in mammalian systems as a decoy, to prevent viral replication. So if this is happening in covid-19 by way of CA, then increased CA activity would be decreasing viral load.

Aside from that, we have better reason to suspect CD147 as the route of RBC damage. I brought this up earlier and you still haven’t commented: CD147 is a known route of infection for sars-cov-2. No speculating is necessary.. and CD147 is expressed by RBCs. There are other ideas out there as well about RBC damage. I think you're clinging too tightly to sars-cov-2 binding CA without offering much in support of the idea.. only that another pathogen has been found to bind it. I don't even think you've named the other pathogen. Maybe there's something I'm missing here?

Georgia Hunter said...
As for experiments with CA Inhibitors, yes, they have been done.


In covid-19? I could not find this.

Georgia Hunter said...
I don't agree with your statement on selecting hosts it would more likely kill.


This is a misunderstanding.. check my post again including the quote of yours that I was responding to. I believe we are on the same page now: binding to CA would be a feature that harms sars-cov-2 in natural selection (“survival of the fittest”).

Georgia Hunter said...
Internal molecules often determine the exterior configuration of a membrane bound molecule. That is just common molecular biology.


Yeah I am admittedly out of my comfort zone here but I am familiar with attachment sites being altered in this way. Before I thought you were saying the virus could still attach to cells via ACE2 but not enter when CA was involved. Anyway, I’m not comfortable with an assumption that CA alters the configuration of ACE-2 so that sars-cov-2 can no longer attach.. it seems like a pretty big leap to take without evidence. Furthermore I wouldn't even have known we were taking this leap if I didn't scrutinize your statement at the top of this page:

"...there are things that can bind the inside of the ACE2 receptor and prevent entry into the cell. Carbonic anhydrase is such an item."

...I mean you said it there as if there was no question.

Also, you previously seemed to be saying that sars-cov-2 binding to CA increases viral load (but now we’ve settled on the opposite). How else can you explain this statement from the op:

"Big molecules like Ivermectin that have a lot of stereochemistry may block the viral binding to carbonic anhydrase and stop replication"

...sure sounds like you thought the virus was binding CA in order to replicate inside RBCs. I gotta wonder how much of this is being made up as we go.
profile picture
Georgia Hunter
Veteran Member
Joined : May 2012
Posts : 2601
Posted 12/27/2020 6:38 PM (GMT -7)
I'm just going to give up because you do not understand what I am trying to say. You do not have to believe what I am saying, that is fine. Until they find out what is going on, I am sticking with my statements. Everything I find is supporting it.

I mentioned CD147 in one post and how it binds CA IV but that is extracellular. That is different. I think CD147 comes into play as things start going south because of the pyruvate and lactate.

One more time, my opinion is that if CA II is attached to ACE2, the virus can't enter. If more CO2 is present, then less CA II will be bound to ACE2 and the virus can enter and replicate. The virus binds unattached CA II and prevents it from attaching back to ACE2. CO2 is broken down into HCO3 and water raising pH until CO2 eventually builds up which lowers pH inside the cell. No one knows exactly what is going on and I won't speculate any further, there are just too many things that could go wrong.

Yes, I said CA binds ACE2 like it was not in question. It is not a question because it is a fact. I have 53 references saved on my home computer about COVID. I own 11 computers. I have 5 times that number of scientific references saved on my other computers. I am basing my opinion on what I am finding and using TB or malaria to track a parallel path is not a far stretch. I've looked at many more pathogens but they did not fit the progression of disease I was finding. TB can't grow in oxygen and the more CO2 present, the more infectious it is. An article came out this week that Horowitz posted and it said that scientists believe that removing more trees from the earth would increase more viral infections. Our air goes up about 2 ppm of CO2 per year. That just coincides with what I have been saying. Fewer trees, more CO2 and more viruses.

I said that the virus was entering through our eyes and many scoffed at that. I saw an article this week that said that people who wear glasses have a lesser chance of getting COVID than people who don't wear glasses. The numbers were about 6% of the people who wore glasses got COVID where 31% of that population had glasses.

I don't understand your obsession with RBC's. They have nothing to do with viral replication but the virus can bind the CA II inside them along with heme oxygenase II and prevent the cell from carrying as much oxygen. This is what ultimately causes breathing difficulty.

As for articles on CA inhibitors and COVID, the first search I looked at showed 1780 references. On the first page 5 articles were directly related to it. I didn't look any farther.
profile picture
potsnpans
Veteran Member
Joined : Mar 2019
Posts : 799
Posted 12/28/2020 5:24 AM (GMT -7)

GeorgiaHunter said...
I'm just going to give up because you do not understand what I am trying to say


I understand that there is a difference in what you said on page 1, and what you are saying on page 2.

GeorgiaHunter said...
I mentioned CD147 in one post and how it binds CA IV but that is extracellular. That is different.


Sars-cov-2 binds CD147

GeorgiaHunter said...
One more time, my opinion is that if CA II is attached to ACE2, the virus can't enter. If more CO2 is present, then less CA II will be bound to ACE2 and the virus can enter and replicate. The virus binds unattached CA II and prevents it from attaching back to ACE2. CO2 is broken down into HCO3 and water raising pH until CO2 eventually builds up which lowers pH inside the cell. No one knows exactly what is going on and I won't speculate any further, there are just too many things that could go wrong.


This is how I understood it before I wrote my last post.

GeorgiaHunter said...
Yes, I said CA binds ACE2 like it was not in question. It is not a question because it is a fact.


This is a misunderstanding. The leap of faith that was stated as being without question is that this can "prevent entry into the cell" ..top of page 2 when you said "CA is one of those items".

GeorgiaHunter said...
I don't understand your obsession with RBC's. They have nothing to do with viral replication but the virus can bind the CA II inside them along with heme oxygenase II and prevent the cell from carrying as much oxygen. This is what ultimately causes breathing difficulty.


Well my "obsession" came because of your inconsistency. I was making sense of "binding CA increases viral load".

Hypoxia (and hypercapnia) are probably better explained by CD147.

GeorgiaHunter said...
As for articles on CA inhibitors and COVID, the first search I looked at showed 1780 references. On the first page 5 articles were directly related to it. I didn't look any farther


So you don't know the answer to my question, but you continue to make it sound as if the answer would support your hypothesis. What were you talking about when you said this:

"As for experiments with CA Inhibitors, yes, they have been done. In low doses early in the disease process, they were beneficial. At a point later in disease progression, they become extremely detrimental. This follows my thinking"

For whatever reason, it seems you have too much skin in this for an unbiased discussion.
profile picture
Georgia Hunter
Veteran Member
Joined : May 2012
Posts : 2601
Posted 12/29/2020 11:02 AM (GMT -7)
Please search acetazolamide and COVID. You are acting like there has been no use of CA Inhibitors in COVID patients.

Think a little for me, if SARS-Cov-2 binds CD147, and CD147 binds CA, then is it possible for SARS-Cov-2 to bind CA? I said in March that SARS-Cov-2 had a 32 kDa terminal end protein but haven't seen any literature to get closer to that hypothesis. The science isn't there yet.

I stand my my statement of the virus binding CA increases viral load. You can say that it is not true but nothing has been shown to prove it is not true. Combined with the other things I've found about the virus, I stand by the statement. I may be proven wrong next week but that is science. That is why it is called a hypothesis.
profile picture
potsnpans
Veteran Member
Joined : Mar 2019
Posts : 799
Posted 12/30/2020 5:15 AM (GMT -7)

Georgia Hunter said...
Please search acetazolamide and COVID. You are acting like there has been no use of CA Inhibitors in COVID patients.


I asked if CA inhibitors have been used in covid-19 patients because I genuinely did not know the answer. I just searched again, this time specifically for "acetazolamide and covid", and again I couldn't verify what you have said.

I did come across an older article that describes acetazolamide use for patients with high altitude pulmonary edema (HAPE). It then compares HAPE to covid-19, and on that basis it proposes acetazolamide for experimental use in covid-19. Given this, it seems likely that some doctor somewhere in the world has tried it.. though I'm left curious as to where you found your info on "experiments with CA inhibitors".

Georgia Hunter said...
Think a little for me, if SARS-Cov-2 binds CD147, and CD147 binds CA, then is it possible for SARS-Cov-2 to bind CA?


Yes, though you are again avoiding the reason I brought up CD147. I don't think we need to wait for a new scientific discovery to explain much of the pathology that you have been trying to explain.

Georgia Hunter said...
I stand my my statement of the virus binding CA increases viral load. You can say that it is not true but nothing has been shown to prove it is not true.


Proving it is not true is an impossible task, at least with my limited base of knowledge. I just found it odd how when you went into the details, you only provided ways in which the binding of CA would prevent viral replication.
profile picture
Georgia Hunter
Veteran Member
Joined : May 2012
Posts : 2601
Posted 12/31/2020 2:17 PM (GMT -7)
What is the reason you brought up CD147?
profile picture
dcd2103
Veteran Member
Joined : Nov 2019
Posts : 1183
Posted 12/31/2020 2:30 PM (GMT -7)

potsnpans said...

Aside from that, we have better reason to suspect CD147 as the route of RBC damage. I brought this up earlier and you still haven’t commented: CD147 is a known route of infection for sars-cov-2. No speculating is necessary.. and CD147 is expressed by RBCs. There are other ideas out there as well about RBC damage. I think you're clinging too tightly to sars-cov-2 binding CA without offering much in support of the idea.. only that another pathogen has been found to bind it. I don't even think you've named the other pathogen. Maybe there's something I'm missing here?

Right there

Edit: Didn’t mean that to sound snippy!

Post Edited (dcd2103) : 12/31/2020 2:58:31 PM (GMT-7)

profile picture
Georgia Hunter
Veteran Member
Joined : May 2012
Posts : 2601
Posted 1/1/2021 3:23 AM (GMT -7)
CD147 is certainly involved in the process, it's one of several things that "go wrong." IMO, the cellular dysfunction that occurs is because of a cellular pH issue. One of the things that CD147 does is facilitate the transport of lactate and pyruvate through the cell membrane. Altering that function could certainly cause pH issues and may play a big factor in the progression of the disease. I see it as not being a first stage problem but occurring after having CA issues. The main cellular buffering agent is CA making HCO3 and that is why I focused on it. Add in that other pathogens are known to alter its level and that is why I went in that direction. I have no agenda and will focus elsewhere when and if turns out to be a dead end. I have only found things to strengthen my argument, not weaken it.
profile picture
potsnpans
Veteran Member
Joined : Mar 2019
Posts : 799
Posted 1/1/2021 1:57 PM (GMT -7)
What symptoms or disease markers are you attempting to explain exactly... or in other words, what do you feel cannot be adequately explained without your hypothesis?
profile picture
Georgia Hunter
Veteran Member
Joined : May 2012
Posts : 2601
Posted 1/3/2021 3:10 PM (GMT -7)
This article basically explains what I say happens in COVID patients. Just replace endometriosis with COVID and for the most part, everything fits as far as progression of disease. COVID is much more severe and causes the RBC's to no longer carry as much oxygen.

https://www.sciencedirect.com/science/article/abs/pii/s1472648314000728
profile picture
potsnpans
Veteran Member
Joined : Mar 2019
Posts : 799
Posted 1/4/2021 2:24 PM (GMT -7)
How do you map that article onto what we know about covid-19 (symptoms, disease markers, causes of death)? What makes you say "everything fits"?
✚ New Topic ✚ Reply
123




HealingWell

About Us  |   Advertise  |   Subscribe  |   Privacy & Disclaimer
Connect With Us
FacebookFacebook TwitterTwitter PinterestPinterest LinkedInLinkedIn
© 1997-2021 HealingWell.com LLC All Rights Reserved. Our website is for informational purposes only. HealingWell.com LLC does not provide medical advice, diagnosis, or treatment.